AAN 2026: Future Directions in RRMS Management
Dr Chu-Yueh Guo discusses how RRMS care is diversifying beyond standard B-cell therapies with new agents and a renewed focus on preventive strategies. Medscape
Original Source
Read the full article at Medscape →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.